Across the past 12 months, Sunshine Biopharma insiders reported no open-market purchases or sales.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | David Natan | Director | 68,300 | 0 | 68,300 | 100.0% | 11 Aug, 2026 |
| 2 | Camille Sebaaly | Cfo/Secretary | 9 | 0 | 9 | 0.0% | 01 Dec, 2022 |
| 3 | Steve N. Slilaty | Chief Executive Officer | 7 | 0 | 7 | 0.0% | 05 Mar, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 07 Aug, 2026 | David Natan | Director | Acquired A | 58,300 | $0.00 | $0 | 68,300 | Direct |
| 14 Apr, 2026 | David Natan | Director | Acquired A | 100,000 | $0.00 | $0 | 10,000 | Direct |
| 04 Mar, 2024 | Steve N. Slilaty | Chief Executive Officer | Acquired P | 100,000 | $2,000.00 | $200.00Mn | 7 | Direct |
| 08 Feb, 2024 | Steve N. Slilaty | Chief Executive Officer | Acquired P | 20,000 | $2,000.00 | $40.00Mn | 2 | Direct |
| 30 Nov, 2022 | Camille Sebaaly | Cfo/Secretary | Acquired P | 30,000 | $15,270.00 | $458.10Mn | 9 | Direct |
| 03 Jun, 2022 | Camille Sebaaly | Cfo/Secretary | Acquired P | 25,000 | $24,400.00 | $610.00Mn | 7 | Direct |
| 18 Feb, 2022 | Steve N. Slilaty | Chief Executive Officer | Disposed D | 990,000 | $2,000.00 | $1.98Bn | 1 | Direct |
| 06 Jan, 2021 | Steve N. Slilaty | Chief Executive Officer | Acquired A | 20,000,000 | $4,000.00 | $80.00Bn | 6 | Direct |
| 06 Jan, 2021 | Camille Sebaaly | Cfo/Secretary | Acquired A | 20,000,000 | $4,000.00 | $80.00Bn | 6 | Direct |
| 06 Jan, 2021 | Abderrazzak Merzouki | Chief Operating Officer | Acquired A | 20,000,000 | $4,000.00 | $80.00Bn | 6 | Direct |
| 17 Jun, 2020 | Steve N. Slilaty | Chief Executive Officer | Acquired A | 500,000 | $400,000.00 | $200.00Bn | 0 | Direct |
| 02 Sep, 2019 | Steve N. Slilaty | Chief Executive Officer | Acquired A | 13,000,000 | $80,000.00 | $1.04Tn | 0 | Direct |
| 02 Sep, 2019 | Camille Sebaaly | Secretary | Acquired A | 13,000,000 | $80,000.00 | $1.04Tn | 0 | Direct |
| 11 Sep, 2019 | Camille Sebaaly | Secretary | Acquired A | 11,000,000 | $80,000.00 | $880.00Bn | 0 | Direct |
| 02 Sep, 2019 | Abderrazzak Merzouki | Chief Operating Officer | Acquired A | 13,000,000 | $80,000.00 | $1.04Tn | 0 | Direct |
| 27 Aug, 2018 | Steve N. Slilaty | Chief Executive Officer | Acquired A | 38,000,000 | $1,600,000.00 | $60.80Tn | 0 | Direct |
| 27 Aug, 2018 | Camille Sebaaly | Secretary | Acquired A | 38,000,000 | $1,600,000.00 | $60.80Tn | 0 | Direct |
| 27 Aug, 2018 | Abderrazzak Merzouki | Chief Operating Officer | Acquired A | 38,000,000 | $1,600,000.00 | $60.80Tn | 0 | Direct |
| 20 Jun, 2018 | Steve N. Slilaty | Chief Executive Officer | Acquired A | 27,000,000 | $1,600,000.00 | $43.20Tn | 0 | Direct |
| 20 Jun, 2018 | Camille Sebaaly | Secretary | Acquired A | 27,000,000 | $1,600,000.00 | $43.20Tn | 0 | Direct |